Acute myeloid leukemia in the real world: why population-based registries are needed

Underreporting of Myeloid Malignancies by United States Cancer Registries

(2012) B. M. Craig et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Most 70- to 79-year-old patients with acute myeloid leukemia do benefit from intensive treatment

(2011) G. Juliusson et al.   BLOOD

Publication bias is present in blood and marrow transplantation: an analysis of abstracts at an international meeting

(2011) K. Paulson et al.   BLOOD

Applicability of a "Pick a Winner" trial design to acute myeloid leukemia

(2011) R. K. Hills et al.   BLOOD

Lack of clarity in the definition of treatment-related mortality: pediatric acute leukemia and adult acute promyelocytic leukemia as examples

(2011) M.-C. Ethier et al.   BLOOD

Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid

(2011) J. H. Park et al.   BLOOD

Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007

(2011) G. M. Dores et al.   BLOOD

Underascertainment of radiotherapy receipt in Surveillance, Epidemiology, and End Results registry data

(2011) Reshma Jagsi et al.   CANCER

Deciphering surveillance, epidemiology, and end results data analysis

(2011) Kate E. Oliver et al.   CANCER

Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia

(2011) Gunnar Juliusson et al.   CANCER

Older Patients With Acute Myeloid Leukemia Benefit From Intensive Chemotherapy: An Update From the Swedish Acute Leukemia Registry

(2011) Gunnar Juliusson   Clinical Lymphoma Myeloma & Leukemia

Treatment advances have not improved the early death rate in acute promyelocytic leukemia

(2011) J. S. McClellan et al.   HAEMATOLOGICA

Prediction of Early Death After Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia With Pretreatment Risk Scores: A Novel Paradigm for Treatment Assignment

(2011) Roland B. Walter et al.   JOURNAL OF CLINICAL ONCOLOGY

Modern Approaches to Treating Acute Promyelocytic Leukemia

(2011) Miguel A. Sanz et al.   JOURNAL OF CLINICAL ONCOLOGY

Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry

(2011) S Lehmann et al.   LEUKEMIA

Blood, sex and tears: speculations on the gender imbalance in hematologic malignancies

(2011) Janette van den Berghe et al.   LEUKEMIA & LYMPHOMA

Geographic Variation in Physicians' Responses to a Reimbursement Change

(2011) Mireille Jacobson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Population-based analyses in adult acute lymphoblastic leukemia

(2010) G. Juliusson et al.   BLOOD

Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm

(2010) R. B. Walter et al.   BLOOD

A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia

(2010) T. A. Fehniger et al.   BLOOD

Acquisition of genome-wide copy number alterations in monozygotic twins with acute lymphoblastic leukemia

(2010) C. M. Bateman et al.   BLOOD

Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia

(2010) H. Kantarjian et al.   BLOOD

Bone marrow transplantation in AML, and socioeconomic class: a UK population-based cohort study

(2010) Fatima Bhayat et al.   BMC CANCER

The EBMT activity survey 2008: impact of team size, team density and new trends

(2010) A Gratwohl et al.   BONE MARROW TRANSPLANTATION

Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial

(2010) Alan K. Burnett et al.   JOURNAL OF CLINICAL ONCOLOGY

Population genetics meets cancer genomics

(2010) R. R. Regoes   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

(2009) H. Dohner et al.   BLOOD

The incidence of and mortality from leukaemias in the UK: a general population-based study

(2009) Fatima Bhayat et al.   BMC CANCER

Do commonly used clinical trial designs reflect clinical reality?

(2009) E. Estey   HAEMATOLOGICA

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission

(2009) John Koreth et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Attempts to Optimize Induction and Consolidation Treatment in Acute Myeloid Leukemia: Results of the MRC AML12 Trial

(2009) Alan K. Burnett et al.   JOURNAL OF CLINICAL ONCOLOGY

Anthracycline Dose Intensification in Acute Myeloid Leukemia

(2009) Hugo F. Fernandez et al.   NEW ENGLAND JOURNAL OF MEDICINE

Variation in Supportive Care Practices in Hematopoietic Cell Transplantation

(2008) Stephanie J. Lee et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

(2008) G. Juliusson et al.   BLOOD

Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005

(2008) A. R. Derolf et al.   BLOOD

A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1)

(2008) A. Liso et al.   HAEMATOLOGICA

Relevance of clinical trials in acute myeloid leukaemia

(2008) Apostolia M. Tsimberidou et al.   HEMATOLOGICAL ONCOLOGY

Mathematical Models of Cancer Stem Cells

(2008) Franziska Michor   JOURNAL OF CLINICAL ONCOLOGY

Treatment of Adult Acute Lymphoblastic Leukemia

(2008) Nicola Gökbuget et al.   SEMINARS IN HEMATOLOGY